1 July 2018 - They are two women from the same city who have exactly the same deadly disease.
But while Anna Cattalini qualifies for a new drug that can extend the lives of women suffering from metastic breast cancer, Kerry Rogers does not.
From today the drug known as Kisqali is listed on the PBS bringing hope to women like Mrs Cattalini, a 50-year-old mother-of-three, who would otherwise have to pay around $5,000 a month for the treatment.